GridAI Technologies (GRDX) Common Equity (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Common Equity came in at $24.9 million in Q4 2025, up 743.4% YoY from $3.0 million in Q4 2024, and down 10.54% on a QoQ basis from $27.9 million in Q3 2025.
GridAI Technologies (GRDX) Common Equity (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Common Equity data on file, last reported at $24.9 million in Q4 2025.
- Quarterly Common Equity rose 743.4% year-over-year to $24.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.9 million (up 743.4% YoY) and the FY2025 annual result came in at $24.9 million, up 743.4% from the prior year.
- Common Equity fell to $24.9 million in Q4 2025, from $27.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $27.9 million in Q3 2025 to a low of -$14.2 million in Q2 2022.
- A 5-year average of $3.3 million and a median of $2.7 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2021 — Common Equity surged 982.43% — and 2022, when it slumped 301.65%.
- Tracing GRDX's Common Equity over 5 years: stood at -$7.8 million in 2021, then jumped by 135.06% to $2.7 million in 2022, then surged by 31.39% to $3.6 million in 2023, then sank by 207.6% to -$3.9 million in 2024, then surged by 743.4% to $24.9 million in 2025.
- The last three Common Equity figures came in at $24.9 million (Q4 2025), $27.9 million (Q3 2025), and -$6.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 9.79 Bn |
| 10 | GridAI Technologies | 6.26 Mn | 6.26 Mn | - | 24.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.94 Mn |
| Sep 30, 2025 | 27.88 Mn |
| Jun 30, 2025 | -6.30 Mn |
| Mar 31, 2025 | -5.22 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | 8.37 Mn |
| Jun 30, 2024 | 9.12 Mn |
| Mar 31, 2024 | 16.18 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 3.28 Mn |
| Jun 30, 2023 | 881,960.00 |
| Mar 31, 2023 | 2.71 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Sep 30, 2022 | -2.28 Mn |
| Jun 30, 2022 | -14.19 Mn |
| Mar 31, 2022 | -9.24 Mn |
| Dec 31, 2021 | -7.82 Mn |
| Sep 30, 2021 | -6.97 Mn |
| Jun 30, 2021 | 7.04 Mn |
| Mar 31, 2021 | 14.40 Mn |